Company Monitoring Page for Ironwood-Pharmaceuticals

latest headlines for company on cafepharma

Mon, 07/16/18 - 09:06 am
Tags:
Ironwood Pharmaceuticals, Allergan, linaclotide, Linzess, IBS-C
Ironwood’s preparation for activist-driven R&D split puts 40 staffers out of work
Fierce Pharma
Thu, 07/5/18 - 07:41 pm
Tags:
Ironwood Pharmaceuticals, R&D, layoffs
Ironwood Pharma’s Sickle Cell Drug Gets Orphan Drug Designation
BioSpace
Sun, 06/10/18 - 07:03 pm
Tags:
Ironwood Pharmaceuticals, FDA, sickle cell disease, olinciguat, orphan drug
Ironwood pushing through mid-stage trials with nephropathy drug
BioPharma Dive
Tue, 12/5/17 - 09:35 am
Tags:
Ironwood Pharmaceuticals, clinical trials, diabetic nephropathy, IW-1973
Allergan: Is Linzess 'Restasis 2.0'?
NY Shock Exchange
Mon, 10/23/17 - 09:42 am
Tags:
Allergan, Restasis, patents, Linzess, Ironwood Pharmaceuticals, Teva Pharmaceutical, IBS-C
Ironwood zeroes in on primary care doctors with new gout combo med Duzallo
Fierce Pharma
Wed, 08/23/17 - 11:15 am
Tags:
Ironwood Pharmaceuticals, gout, Duzallo, primary care
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
BioPharma Dive
Wed, 04/27/16 - 02:11 pm
Tags:
AstraZeneca, Zurampic, Ironwood Pharmaceuticals, gout
Ironwood exec's brainstorm gives Allergan a marketing edge with Linzess
Fierce Pharma Marketing
Thu, 04/7/16 - 09:44 pm
Tags:
Ironwood Pharmaceuticals, Allergan, Linzess
Is This Ironwood Pharmaceuticals' Biggest Threat?
Motley Fool
Mon, 03/21/16 - 09:11 am
Tags:
Ironwood Pharmaceuticals, Linzess, plecanatide, Synergy Pharmaceuticals
​Ironwood marks rare milestone: 1 million patients have taken Linzess
Bizjournals.com
Thu, 02/18/16 - 05:53 pm
Tags:
Ironwood Pharmaceuticals, Linzess, IBS-C
3 Biotech Stocks That Are Getting a Heckuva Lot Riskier
Motley Fool
Mon, 08/17/15 - 07:58 am
Tags:
Ironwood Pharmaceuticals, Aegerion, MannKind
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Tags:
Juxtapid, Otezla, Aegerion, Celgene, GW Pharma, Sativex, Intercept Pharma, OCA, Ironwood Pharmaceuticals, Linzess, Lpath, iSONEP, MannKind, Afrezza, Xtandi, H.P. Acthar Gel, Questcor Pharmaceuticals, eteplirsen, Sarepta Therapeutics
Why Ironwood Pharmaceuticals (IRWD) is Poised to Beat Earnings Estimates (Again)
Yahoo/Zacks.com
Wed, 04/23/14 - 09:18 am
Tags:
earnings, Ironwood Pharmaceuticals
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Fri, 02/21/14 - 11:19 am
Tags:
Synergy Pharmaceuticals, IBS-C, Ironwood Pharmaceuticals, Linzess, Sucampo, plecanatide
Narrower-than-Expected Loss at Ironwood, Shares Up
Yahoo/Zacks.com
Wed, 01/22/14 - 05:19 pm
Tags:
earnings, Ironwood Pharmaceuticals
5 Pharmas Spending the Most on Advertising to Physicians in Print Media
Motley Fool
Thu, 09/5/13 - 06:50 pm
Tags:
JNJ, Forest Labs, Pfizer, Novartis, Ironwood Pharmaceuticals
Ironwood Pharma 2Q loss widens, revenue slides
Yahoo/AP
Tue, 07/23/13 - 11:56 am
Tags:
earnings, Ironwood Pharmaceuticals
Ironwood commences first phase of anxiety drug trial in US
Pharmaceutical Business Review
Wed, 12/26/12 - 12:05 pm
Tags:
Ironwood Pharmaceuticals, anxiety, IW-2143
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Tags:
Xtandi, Medivation, prostate cancer, Stribild, Gilead Sciences, HIV, Belviq, Arena Pharmaceuticals, obesity, weight loss, Qsymia, Vivus, Kyprolis, ONYX Pharmaceuticals, Multiple Myeloma, Omontys, Affymax, anemia, Linzess, irritable bowel syndrome, Ironwood Pharmaceuticals, Bosulif, chronic myeloid leukemia, Pfizer, Amyvid, Alzheimer's disease, Eli Lilly, Eylea, macular degeneration, Regeneron
Ironwood long-term outlook positive, says Ladenburg
Yahoo/Fly on the Wall
Tue, 10/23/12 - 04:29 pm
Tags:
Ironwood Pharmaceuticals, linaclotide, AstraZeneca, China

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.